Augmented antitumor effects of erlotinib and cabozantinib on A549 non-small cell lung cancer: In vitro and in vivo studies

• Main Authors: Khalid Alhazzani (Author), Meshal Alsahli (Author), Ahmed Z Alanazi (Author), Mohammad Algahtani (Author), Ahmad A Alenezi (Author), Ali Alhoshani (Author), Mohammed Alqinyah (Author), Abdullah S. Alhamed (Author), Khaled Alhosaini (Author)
• Format: Book
• Published: Elsevier, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Non-small cell lung carcinoma is a challenging disease worldwide. This study aims to determine whether combining erlotinib, an epidermal growth factor receptor (EGFR) inhibitor, with cabozantinib, a mesenchymal-epithelial transition factor (c-Met) inhibitor, would have an augmented therapeutic benef...